Do you care about patient access? The SPC manufacturing waiver can help!

16^th Biosimilar Medicines Conference

14^th Legal Affairs Conference

17^th Regulatory and Scientific Affairs Conference

11^th Medicines for Europe Pharmacovigilance Conference

IGBA 2017 achievements – Adrian van den Hoven

How come that biosimilar medicines are still heavily debated today?

What is needed to familiarize oncologists with biosimilar medicines?

What is the role of clinical trials in biosimilar development?

What are the key messages of the ESMO 2017 symposium?